Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Ohar

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Translational Oncology|March 10, 2015
Changing pattern in malignant mesothelioma survivalJennifer Faig, Suzanne Howard, Edward A Levine, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPDSohini Ghosh, Roy A Pleasants, Jill A Ohar, et al.
Chest|April 6, 2010
Do symptoms predict COPD in smokers?Jill A Ohar, Alireza Sadeghnejad, Deborah A Meyers, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 3, 2025
Use of a Digital Inhaler to Assess COPD Disease Variability and Identify Impending Acute COPD Exacerbations: A Pilot StudyM Bradley Drummond, Caleb C Hemphill, Tanisha Hill, et al.
Chest|April 29, 2020
Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different InhalersChris N Barnes, Donald A Mahler, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2019
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studiesJill A Ohar, Alyssa Bowling, Thomas Goodin, et al.
COPD|June 28, 2019
Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week StudiesJill A Ohar, Sanjay Sharma, Thomas Goodin, et al.
American Journal of Respiratory and Critical Care Medicine|July 7, 2007
IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung functionAlireza Sadeghnejad, Deborah A Meyers, Matteo Bottai, et al.
Respiratory Medicine|January 21, 2023
Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary diseaseJames F Donohue, Gary T Ferguson, Jill A Ohar, et al.
Cancer Letters|September 28, 2015
Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interactionMitchell Cheung, Yuwaraj Kadariya, Jacqueline Talarchek, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Translational Oncology|March 10, 2015
Changing pattern in malignant mesothelioma survivalJennifer Faig, Suzanne Howard, Edward A Levine, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPDSohini Ghosh, Roy A Pleasants, Jill A Ohar, et al.
Chest|April 6, 2010
Do symptoms predict COPD in smokers?Jill A Ohar, Alireza Sadeghnejad, Deborah A Meyers, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 3, 2025
Use of a Digital Inhaler to Assess COPD Disease Variability and Identify Impending Acute COPD Exacerbations: A Pilot StudyM Bradley Drummond, Caleb C Hemphill, Tanisha Hill, et al.
Chest|April 29, 2020
Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different InhalersChris N Barnes, Donald A Mahler, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2019
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studiesJill A Ohar, Alyssa Bowling, Thomas Goodin, et al.
COPD|June 28, 2019
Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week StudiesJill A Ohar, Sanjay Sharma, Thomas Goodin, et al.
American Journal of Respiratory and Critical Care Medicine|July 7, 2007
IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung functionAlireza Sadeghnejad, Deborah A Meyers, Matteo Bottai, et al.
Respiratory Medicine|January 21, 2023
Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary diseaseJames F Donohue, Gary T Ferguson, Jill A Ohar, et al.
Cancer Letters|September 28, 2015
Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interactionMitchell Cheung, Yuwaraj Kadariya, Jacqueline Talarchek, et al.
Pageof 6